메뉴 건너뛰기




Volumn 52, Issue 12, 2014, Pages 1105-1111

Peramivir pharmacokinetics in a patient receiving continuous veno-venous hemodiafiltration during the 2009 H1N1 influenza a pandemic

Author keywords

Continuous veno venous hemo diafiltration; CVVHDF; Influenza A(H1N1)pdm09; Peramivir; Pharmacokinetics

Indexed keywords

LEVOFLOXACIN; OSELTAMIVIR; PERAMIVIR; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN; ANTIVIRUS AGENT; CYCLOPENTANE DERIVATIVE; GUANIDINE DERIVATIVE; SIALIDASE;

EID: 84929655882     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CP202161     Document Type: Article
Times cited : (10)

References (11)
  • 4
    • 84897142275 scopus 로고    scopus 로고
    • Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1NA pdm09 virus infection: A meta-analysis of individual participant data
    • Muthuri SG, Venkatesan S, Myles PR, Leonardi-Bee J, Al Khuwaitir TS, Al Mamun A, et al. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1NA pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med. 2014;2:395-404.
    • (2014) Lancet Respir Med. , vol.2 , pp. 395-404
    • Muthuri, S.G.1    Venkatesan, S.2    Myles, P.R.3    Leonardi-Bee, J.4    Al Khuwaitir, T.S.5    Mamun, A.A.6
  • 5
    • 84878816633 scopus 로고    scopus 로고
    • Acute kidney injury among critically ill patients with pandemic H1N1 influenza A in Canada: Cohort study
    • Bagshaw SM, Sood MM, Long J, Fowler RA, Adhikari NKJ; Canadian Critical Care Trials Group H1N1 Collaborative. Acute kidney injury among critically ill patients with pandemic H1N1 influenza A in Canada: cohort study. BMC Nephrol. 2013;14:123.
    • (2013) BMC Nephrol. , vol.14 , pp. 123
    • Bagshaw, S.M.1    Sood, M.M.2    Long, J.3    Fowler, R.A.4    Adhikari, N.K.J.5
  • 6
    • 15244356880 scopus 로고    scopus 로고
    • Defining, quantifying, and classifying acute renal failure
    • Bellomo R. Defining, quantifying, and classifying acute renal failure. Crit Care Clin. 2005;21:223-237.
    • (2005) Crit Care Clin. , vol.21 , pp. 223-237
    • Bellomo, R.1
  • 8
    • 77957685731 scopus 로고    scopus 로고
    • Peramivir pharmacokinetics in two critically ill adults with 2009 H1N1 influenza A concurrently receiving continuous renal replacement therapy
    • Bazan JA, Bauer KA, Hollister AS, Shidham G, Firstenberg MS, Reed EE, Mangino JE, Goff DA. Peramivir pharmacokinetics in two critically ill adults with 2009 H1N1 influenza A concurrently receiving continuous renal replacement therapy. Pharmacotherapy. 2010;30:1016-1020.
    • (2010) Pharmacotherapy , vol.30 , pp. 1016-1020
    • Bazan, J.A.1    Bauer, K.A.2    Hollister, A.S.3    Shidham, G.4    Firstenberg, M.S.5    Reed, E.E.6    Mangino, J.E.7    Goff, D.A.8
  • 9
    • 83155182919 scopus 로고    scopus 로고
    • Pharmacokinetic assessment of peramivir in a hospitalized adult undergoing continuous venovenous hemofiltration
    • Scheetz MH, Griffith MM, Ghossein C, Hollister AS, Ison MG. Pharmacokinetic assessment of peramivir in a hospitalized adult undergoing continuous venovenous hemofiltration. Ann Pharmacother. 2011;45:e64.
    • (2011) Ann Pharmacother. , vol.45 , pp. e64
    • Scheetz, M.H.1    Griffith, M.M.2    Ghossein, C.3    Hollister, A.S.4    Ison, M.G.5
  • 10
    • 77955021268 scopus 로고    scopus 로고
    • Peramivir clearance in continuous renal replacement therapy
    • Thomas B, Hollister AS, Muczynski KA. Peramivir clearance in continuous renal replacement therapy. Hemodial Int. 2010;14:339-340.
    • (2010) Hemodial Int. , vol.14 , pp. 339-340
    • Thomas, B.1    Hollister, A.S.2    Muczynski, K.A.3
  • 11
    • 0032878670 scopus 로고    scopus 로고
    • Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltra-tion fow rates
    • Brunet S, Leblanc M, Geadah D, Parent D, Courteau S, Cardinal J. Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltra-tion fow rates. Am J Kidney Dis. 1999;34:486-492.
    • (1999) Am J Kidney Dis. , vol.34 , pp. 486-492
    • Brunet, S.1    Leblanc, M.2    Geadah, D.3    Parent, D.4    Courteau, S.5    Cardinal, J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.